Encompass Health/$EHC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Encompass Health

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Ticker

$EHC
Sector

Primary listing

NYSE

Employees

28,678

Encompass Health Metrics

BasicAdvanced
$12B
24.20
$5.11
0.80
$0.70
0.61%

What the Analysts think about Encompass Health

Analyst ratings (Buy, Hold, Sell) for Encompass Health stock.

Bulls say / Bears say

Net operating revenue grew 12.0% year-over-year to $1,457.7 million in Q2 2025 while adjusted EPS rose 26.1% to $1.40, supported by 7.2% discharge growth and 4.2% pricing gains. (PRNewswire)
Management raised the full-year 2025 outlook, increasing revenue guidance to $5,880 million–$5,980 million and adjusted EBITDA guidance to $1,220 million–$1,250 million, signaling confidence in continued growth. (PRNewswire)
In Q2 2025, Encompass Health boosted capacity by opening a new 60-bed hospital in Fort Myers, Florida, and adding 26 beds to an existing hospital, supporting future revenue growth. (PRNewswire)
As of June 30, 2025, Encompass Health had net long-term debt of $2.32 billion compared to shareholders’ equity of $2.28 billion, resulting in a debt-to-equity ratio above 1.0x that could limit financial flexibility as interest rates rise. (PRNewswire)
Encompass Health projects $785 million to $820 million in capital expenditures for 2025, including roughly $380 million for projects in progress, which may put pressure on free cash flow and increase dependence on debt financing. (SEC)
The CMS proposal to widen coverage of home-based health services could divert patient volume from inpatient rehabilitation hospitals like Encompass Health, potentially lowering discharges and revenue. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.

Encompass Health Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Encompass Health Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $EHC

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs